Results 181 to 190 of about 89,230 (317)

Dual Portal Hypertension in Hepatic Tuberculosis: A Case Report. [PDF]

open access: yesGE Port J Gastroenterol
Joseph A   +3 more
europepmc   +1 more source

Clearance of Hepatitis C Viremia During Direct‐Acting Antiviral Therapy Leads to Rapid Changes in Lipid and Lipoprotein Metabolism

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
HCV clearance during direct‐acting antiviral therapy rapidly increases serum lipids and lipoproteins, potentially elevating cardiovascular risk. These metabolic changes, mediated by genes regulating hepatic lipogenesis, suggest that lipid levels should be closely monitored post‐SVR to assess long‐term cardiovascular implications.
Zahra Sarrafan‐Chaharsoughi   +12 more
wiley   +1 more source

Scleroderma and portal hypertension. [PDF]

open access: bronze, 1972
J Morris, T Htut, Alexandra E. Read
openalex   +1 more source

Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension. [PDF]

open access: yesFront Med (Lausanne)
Li Y   +8 more
europepmc   +1 more source

Diabetes Mellitus in Patients With Autoimmune Hepatitis: Frequency, Risk Factors and Effect on Outcome

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
New‐onset DM occurred in 13% of patients with AIH, was related to older age, non‐Caucasian ethnicity, higher prednisolone dose, higher BMI at diagnosis and weight gain and was an independent predictor of all‐cause death/transplantation and of cirrhosis development, underlining the need to minimise steroid burden in AIH.
Sarah Flatley   +6 more
wiley   +1 more source

A novel noninvasive assessment of portal pressure from computational biofluid mechanics in patients with portal hypertension. [PDF]

open access: yesTrials
Zheng L   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy